Summary:

In every life science company there are experienced professionals who are concerned their organization is being too risk-adverse, taking an overly conservative approach to validation, and therefore spending unnecessary time and money. In the same companies there are inevitably other professionals that are concerned that their organization is at severe regulatory risk due to inadequate validation practices. Where is the middle ground? By adopting a risk-based approach, organizations can more efficiently validate systems while still adhering to regulation requirements.